Outbreak of vancomycin-resistant Enterococcus in a renal transplant unit

Brazilian Journal of Infectious Diseases

Volumn 15, Issue 4, 2011, Pages 403-405

  Tuon, Felipe Francisco ^a   Penteado Filho, Sergio Ricardo ^a   Camilotti, Janaina ^a   van der Heijden, Inneke Marie ^b   Costa, Silvia Figueiredo ^b  

^a HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFEPIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ASEPSIS; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BRAZIL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; EDUCATION PROGRAM; ENTEROCOCCAL INFECTION; EPIDEMIC; FEMALE; HUMAN; INFECTION CONTROL; KIDNEY TRANSPLANTATION; LETTER; MALE; PROTECTIVE CLOTHING; RISK FACTOR; UNIVERSITY HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 80052396434     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1590/S1413-86702011000400021     Document Type: Letter

References (14)

1. Freitas M.C., Pacheco-Silva A., Barbosa D., et al. Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients. BMC Infect Dis 2006, 6:133.
2. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute. Fifteenth Informational Supplement 2005, Clinical and Laboratory Standards Institute, Pennsylvania, USA, Ref Type: Serial (Book,Monograph).
3. Petrich A.K., Luinstra K.E., Groves D., et al. Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR. Mol Cell Probes 1999, 13:275-281.
4. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
5. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003, 24:362-386.
6. Carmeli Y., Eliopoulos G.M., Samore M.H. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002, 8:802-807.
7. Askarian M., Afkhamzadeh R., Monabbati A., et al. Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz, Iran. Int J Infect Dis 2008, 12:171-175.
8. Muto C.A., Giannetta E.T., Durbin L.J., et al. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 2002, 23:429-435.
9. Aumeran C., Baud O., Lesens O., et al. Successful control of a hospital-wide vancomycin-resistant Enterococcus faecium outbreak in France. Eur J Clin Microbiol Infect Dis 2008, 27(11):1061-1064.
10. Schmidt-Hieber M., Blau I.W., Schwartz S., et al. Intensified strategies to control vancomycin-resistant enterococci in immunocompromised patients. Int J Hematol 2007, 86:158-162.
11. Ott M., Wirick H. Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker. Can Oper Room Nurs J 2008, 26:21-29. 32.
12. Kurup A., Chlebicki M.P., Ling M.L., et al. Control of a hospital-wide vancomycin-resistant enterococci outbreak. Am J Infect Control 2008, 36:206-211.
13. Peta M., Carretto E., Barbarini D., et al. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Clin Microbiol Infect 2006, 12:163-169.
14. Vernon M.O., Hayden M.K., Trick W.E., et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006, 166:306-312.